Global Felodipine Tablets Market Growth 2022-2028

Publication Month: Oct 2022 | No. of Pages: 99 Published By: LP Information
Single User License: US $ 3660
Corporate User License: US $ 7320

Felodipine is a calcium channel blocker. It works by affecting the movement of calcium into the cells of the heart and blood vessels. Felodipine relaxes blood vessels and increases the supply of blood and oxygen to the heart, which reduces the workload. 
The global market for Felodipine Tablets is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Felodipine Tablets market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Felodipine Tablets market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Felodipine Tablets market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Felodipine Tablets market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Felodipine Tablets players cover Astrazeneca, Sandoz, SHANXI KANGBO BIOLOGICAL PRODUCT, Changzhou Siyao Pharmaceutical and Lianhuan Pharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Felodipine Tablets market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Felodipine Tablets market, with both quantitative and qualitative data, to help readers understand how the Felodipine Tablets market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Felodipine Tablets market and forecasts the market size by Type (Ordinary Tablet and Sustained Release Tablet,), by Application (Treat High Blood Pressure, Relieve Angina and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Ordinary Tablet
Sustained Release Tablet
Segmentation by application
Treat High Blood Pressure
Relieve Angina
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Astrazeneca
Sandoz
SHANXI KANGBO BIOLOGICAL PRODUCT
Changzhou Siyao Pharmaceutical
Lianhuan Pharma
Sihuan Pharma
CR Double Crane
Xiehe Pharma
Chapter Introduction
Chapter 1: Scope of Felodipine Tablets, Research Methodology, etc.
Chapter 2: Executive Summary, global Felodipine Tablets market size (sales and revenue) and CAGR, Felodipine Tablets market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Felodipine Tablets sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Felodipine Tablets sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Felodipine Tablets market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Astrazeneca, Sandoz, SHANXI KANGBO BIOLOGICAL PRODUCT, Changzhou Siyao Pharmaceutical, Lianhuan Pharma, Sihuan Pharma, CR Double Crane and Xiehe Pharma, etc.
Chapter 14: Research Findings and Conclusion

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Felodipine Tablets Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Felodipine Tablets by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Felodipine Tablets by Country/Region, 2017, 2022 & 2028
2.2 Felodipine Tablets Segment by Type
2.2.1 Ordinary Tablet
2.2.2 Sustained Release Tablet
2.3 Felodipine Tablets Sales by Type
2.3.1 Global Felodipine Tablets Sales Market Share by Type (2017-2022)
2.3.2 Global Felodipine Tablets Revenue and Market Share by Type (2017-2022)
2.3.3 Global Felodipine Tablets Sale Price by Type (2017-2022)
2.4 Felodipine Tablets Segment by Application
2.4.1 Treat High Blood Pressure
2.4.2 Relieve Angina
2.4.3 Others
2.5 Felodipine Tablets Sales by Application
2.5.1 Global Felodipine Tablets Sale Market Share by Application (2017-2022)
2.5.2 Global Felodipine Tablets Revenue and Market Share by Application (2017-2022)
2.5.3 Global Felodipine Tablets Sale Price by Application (2017-2022)
3 Global Felodipine Tablets by Company
3.1 Global Felodipine Tablets Breakdown Data by Company
3.1.1 Global Felodipine Tablets Annual Sales by Company (2020-2022)
3.1.2 Global Felodipine Tablets Sales Market Share by Company (2020-2022)
3.2 Global Felodipine Tablets Annual Revenue by Company (2020-2022)
3.2.1 Global Felodipine Tablets Revenue by Company (2020-2022)
3.2.2 Global Felodipine Tablets Revenue Market Share by Company (2020-2022)
3.3 Global Felodipine Tablets Sale Price by Company
3.4 Key Manufacturers Felodipine Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Felodipine Tablets Product Location Distribution
3.4.2 Players Felodipine Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Felodipine Tablets by Geographic Region
4.1 World Historic Felodipine Tablets Market Size by Geographic Region (2017-2022)
4.1.1 Global Felodipine Tablets Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Felodipine Tablets Annual Revenue by Geographic Region
4.2 World Historic Felodipine Tablets Market Size by Country/Region (2017-2022)
4.2.1 Global Felodipine Tablets Annual Sales by Country/Region (2017-2022)
4.2.2 Global Felodipine Tablets Annual Revenue by Country/Region
4.3 Americas Felodipine Tablets Sales Growth
4.4 APAC Felodipine Tablets Sales Growth
4.5 Europe Felodipine Tablets Sales Growth
4.6 Middle East & Africa Felodipine Tablets Sales Growth
5 Americas
5.1 Americas Felodipine Tablets Sales by Country
5.1.1 Americas Felodipine Tablets Sales by Country (2017-2022)
5.1.2 Americas Felodipine Tablets Revenue by Country (2017-2022)
5.2 Americas Felodipine Tablets Sales by Type
5.3 Americas Felodipine Tablets Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Felodipine Tablets Sales by Region
6.1.1 APAC Felodipine Tablets Sales by Region (2017-2022)
6.1.2 APAC Felodipine Tablets Revenue by Region (2017-2022)
6.2 APAC Felodipine Tablets Sales by Type
6.3 APAC Felodipine Tablets Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Felodipine Tablets by Country
7.1.1 Europe Felodipine Tablets Sales by Country (2017-2022)
7.1.2 Europe Felodipine Tablets Revenue by Country (2017-2022)
7.2 Europe Felodipine Tablets Sales by Type
7.3 Europe Felodipine Tablets Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Felodipine Tablets by Country
8.1.1 Middle East & Africa Felodipine Tablets Sales by Country (2017-2022)
8.1.2 Middle East & Africa Felodipine Tablets Revenue by Country (2017-2022)
8.2 Middle East & Africa Felodipine Tablets Sales by Type
8.3 Middle East & Africa Felodipine Tablets Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Felodipine Tablets
10.3 Manufacturing Process Analysis of Felodipine Tablets
10.4 Industry Chain Structure of Felodipine Tablets
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Felodipine Tablets Distributors
11.3 Felodipine Tablets Customer
12 World Forecast Review for Felodipine Tablets by Geographic Region
12.1 Global Felodipine Tablets Market Size Forecast by Region
12.1.1 Global Felodipine Tablets Forecast by Region (2023-2028)
12.1.2 Global Felodipine Tablets Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Felodipine Tablets Forecast by Type
12.7 Global Felodipine Tablets Forecast by Application
13 Key Players Analysis
13.1 Astrazeneca
13.1.1 Astrazeneca Company Information
13.1.2 Astrazeneca Felodipine Tablets Product Offered
13.1.3 Astrazeneca Felodipine Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Astrazeneca Main Business Overview
13.1.5 Astrazeneca Latest Developments
13.2 Sandoz
13.2.1 Sandoz Company Information
13.2.2 Sandoz Felodipine Tablets Product Offered
13.2.3 Sandoz Felodipine Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Sandoz Main Business Overview
13.2.5 Sandoz Latest Developments
13.3 SHANXI KANGBO BIOLOGICAL PRODUCT
13.3.1 SHANXI KANGBO BIOLOGICAL PRODUCT Company Information
13.3.2 SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Tablets Product Offered
13.3.3 SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 SHANXI KANGBO BIOLOGICAL PRODUCT Main Business Overview
13.3.5 SHANXI KANGBO BIOLOGICAL PRODUCT Latest Developments
13.4 Changzhou Siyao Pharmaceutical
13.4.1 Changzhou Siyao Pharmaceutical Company Information
13.4.2 Changzhou Siyao Pharmaceutical Felodipine Tablets Product Offered
13.4.3 Changzhou Siyao Pharmaceutical Felodipine Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Changzhou Siyao Pharmaceutical Main Business Overview
13.4.5 Changzhou Siyao Pharmaceutical Latest Developments
13.5 Lianhuan Pharma
13.5.1 Lianhuan Pharma Company Information
13.5.2 Lianhuan Pharma Felodipine Tablets Product Offered
13.5.3 Lianhuan Pharma Felodipine Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Lianhuan Pharma Main Business Overview
13.5.5 Lianhuan Pharma Latest Developments
13.6 Sihuan Pharma
13.6.1 Sihuan Pharma Company Information
13.6.2 Sihuan Pharma Felodipine Tablets Product Offered
13.6.3 Sihuan Pharma Felodipine Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Sihuan Pharma Main Business Overview
13.6.5 Sihuan Pharma Latest Developments
13.7 CR Double Crane
13.7.1 CR Double Crane Company Information
13.7.2 CR Double Crane Felodipine Tablets Product Offered
13.7.3 CR Double Crane Felodipine Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 CR Double Crane Main Business Overview
13.7.5 CR Double Crane Latest Developments
13.8 Xiehe Pharma
13.8.1 Xiehe Pharma Company Information
13.8.2 Xiehe Pharma Felodipine Tablets Product Offered
13.8.3 Xiehe Pharma Felodipine Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Xiehe Pharma Main Business Overview
13.8.5 Xiehe Pharma Latest Developments
14 Research Findings and Conclusion

Tables and Figures

List of Tables
Table 1. Felodipine Tablets Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Felodipine Tablets Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Ordinary Tablet
Table 4. Major Players of Sustained Release Tablet
Table 5. Global Felodipine Tablets Sales by Type (2017-2022) & (K Units)
Table 6. Global Felodipine Tablets Sales Market Share by Type (2017-2022)
Table 7. Global Felodipine Tablets Revenue by Type (2017-2022) & ($ million)
Table 8. Global Felodipine Tablets Revenue Market Share by Type (2017-2022)
Table 9. Global Felodipine Tablets Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Felodipine Tablets Sales by Application (2017-2022) & (K Units)
Table 11. Global Felodipine Tablets Sales Market Share by Application (2017-2022)
Table 12. Global Felodipine Tablets Revenue by Application (2017-2022)
Table 13. Global Felodipine Tablets Revenue Market Share by Application (2017-2022)
Table 14. Global Felodipine Tablets Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Felodipine Tablets Sales by Company (2020-2022) & (K Units)
Table 16. Global Felodipine Tablets Sales Market Share by Company (2020-2022)
Table 17. Global Felodipine Tablets Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Felodipine Tablets Revenue Market Share by Company (2020-2022)
Table 19. Global Felodipine Tablets Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Felodipine Tablets Producing Area Distribution and Sales Area
Table 21. Players Felodipine Tablets Products Offered
Table 22. Felodipine Tablets Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Felodipine Tablets Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Felodipine Tablets Sales Market Share Geographic Region (2017-2022)
Table 27. Global Felodipine Tablets Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Felodipine Tablets Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Felodipine Tablets Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Felodipine Tablets Sales Market Share by Country/Region (2017-2022)
Table 31. Global Felodipine Tablets Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Felodipine Tablets Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Felodipine Tablets Sales by Country (2017-2022) & (K Units)
Table 34. Americas Felodipine Tablets Sales Market Share by Country (2017-2022)
Table 35. Americas Felodipine Tablets Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Felodipine Tablets Revenue Market Share by Country (2017-2022)
Table 37. Americas Felodipine Tablets Sales by Type (2017-2022) & (K Units)
Table 38. Americas Felodipine Tablets Sales Market Share by Type (2017-2022)
Table 39. Americas Felodipine Tablets Sales by Application (2017-2022) & (K Units)
Table 40. Americas Felodipine Tablets Sales Market Share by Application (2017-2022)
Table 41. APAC Felodipine Tablets Sales by Region (2017-2022) & (K Units)
Table 42. APAC Felodipine Tablets Sales Market Share by Region (2017-2022)
Table 43. APAC Felodipine Tablets Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Felodipine Tablets Revenue Market Share by Region (2017-2022)
Table 45. APAC Felodipine Tablets Sales by Type (2017-2022) & (K Units)
Table 46. APAC Felodipine Tablets Sales Market Share by Type (2017-2022)
Table 47. APAC Felodipine Tablets Sales by Application (2017-2022) & (K Units)
Table 48. APAC Felodipine Tablets Sales Market Share by Application (2017-2022)
Table 49. Europe Felodipine Tablets Sales by Country (2017-2022) & (K Units)
Table 50. Europe Felodipine Tablets Sales Market Share by Country (2017-2022)
Table 51. Europe Felodipine Tablets Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Felodipine Tablets Revenue Market Share by Country (2017-2022)
Table 53. Europe Felodipine Tablets Sales by Type (2017-2022) & (K Units)
Table 54. Europe Felodipine Tablets Sales Market Share by Type (2017-2022)
Table 55. Europe Felodipine Tablets Sales by Application (2017-2022) & (K Units)
Table 56. Europe Felodipine Tablets Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Felodipine Tablets Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Felodipine Tablets Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Felodipine Tablets Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Felodipine Tablets Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Felodipine Tablets Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Felodipine Tablets Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Felodipine Tablets Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Felodipine Tablets Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Felodipine Tablets
Table 66. Key Market Challenges & Risks of Felodipine Tablets
Table 67. Key Industry Trends of Felodipine Tablets
Table 68. Felodipine Tablets Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Felodipine Tablets Distributors List
Table 71. Felodipine Tablets Customer List
Table 72. Global Felodipine Tablets Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Felodipine Tablets Sales Market Forecast by Region
Table 74. Global Felodipine Tablets Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Felodipine Tablets Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Felodipine Tablets Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Felodipine Tablets Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Felodipine Tablets Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Felodipine Tablets Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Felodipine Tablets Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Felodipine Tablets Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Felodipine Tablets Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Felodipine Tablets Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Felodipine Tablets Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Felodipine Tablets Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Felodipine Tablets Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Felodipine Tablets Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Felodipine Tablets Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Felodipine Tablets Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Felodipine Tablets Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Felodipine Tablets Revenue Market Share Forecast by Application (2023-2028)
Table 92. Astrazeneca Basic Information, Felodipine Tablets Manufacturing Base, Sales Area and Its Competitors
Table 93. Astrazeneca Felodipine Tablets Product Offered
Table 94. Astrazeneca Felodipine Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Astrazeneca Main Business
Table 96. Astrazeneca Latest Developments
Table 97. Sandoz Basic Information, Felodipine Tablets Manufacturing Base, Sales Area and Its Competitors
Table 98. Sandoz Felodipine Tablets Product Offered
Table 99. Sandoz Felodipine Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Sandoz Main Business
Table 101. Sandoz Latest Developments
Table 102. SHANXI KANGBO BIOLOGICAL PRODUCT Basic Information, Felodipine Tablets Manufacturing Base, Sales Area and Its Competitors
Table 103. SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Tablets Product Offered
Table 104. SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. SHANXI KANGBO BIOLOGICAL PRODUCT Main Business
Table 106. SHANXI KANGBO BIOLOGICAL PRODUCT Latest Developments
Table 107. Changzhou Siyao Pharmaceutical Basic Information, Felodipine Tablets Manufacturing Base, Sales Area and Its Competitors
Table 108. Changzhou Siyao Pharmaceutical Felodipine Tablets Product Offered
Table 109. Changzhou Siyao Pharmaceutical Felodipine Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Changzhou Siyao Pharmaceutical Main Business
Table 111. Changzhou Siyao Pharmaceutical Latest Developments
Table 112. Lianhuan Pharma Basic Information, Felodipine Tablets Manufacturing Base, Sales Area and Its Competitors
Table 113. Lianhuan Pharma Felodipine Tablets Product Offered
Table 114. Lianhuan Pharma Felodipine Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Lianhuan Pharma Main Business
Table 116. Lianhuan Pharma Latest Developments
Table 117. Sihuan Pharma Basic Information, Felodipine Tablets Manufacturing Base, Sales Area and Its Competitors
Table 118. Sihuan Pharma Felodipine Tablets Product Offered
Table 119. Sihuan Pharma Felodipine Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Sihuan Pharma Main Business
Table 121. Sihuan Pharma Latest Developments
Table 122. CR Double Crane Basic Information, Felodipine Tablets Manufacturing Base, Sales Area and Its Competitors
Table 123. CR Double Crane Felodipine Tablets Product Offered
Table 124. CR Double Crane Felodipine Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. CR Double Crane Main Business
Table 126. CR Double Crane Latest Developments
Table 127. Xiehe Pharma Basic Information, Felodipine Tablets Manufacturing Base, Sales Area and Its Competitors
Table 128. Xiehe Pharma Felodipine Tablets Product Offered
Table 129. Xiehe Pharma Felodipine Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Xiehe Pharma Main Business
Table 131. Xiehe Pharma Latest Developments
List of Figures
Figure 1. Picture of Felodipine Tablets
Figure 2. Felodipine Tablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Felodipine Tablets Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Felodipine Tablets Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Felodipine Tablets Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Ordinary Tablet
Figure 10. Product Picture of Sustained Release Tablet
Figure 11. Global Felodipine Tablets Sales Market Share by Type in 2021
Figure 12. Global Felodipine Tablets Revenue Market Share by Type (2017-2022)
Figure 13. Felodipine Tablets Consumed in Treat High Blood Pressure
Figure 14. Global Felodipine Tablets Market: Treat High Blood Pressure (2017-2022) & (K Units)
Figure 15. Felodipine Tablets Consumed in Relieve Angina
Figure 16. Global Felodipine Tablets Market: Relieve Angina (2017-2022) & (K Units)
Figure 17. Felodipine Tablets Consumed in Others
Figure 18. Global Felodipine Tablets Market: Others (2017-2022) & (K Units)
Figure 19. Global Felodipine Tablets Sales Market Share by Application (2017-2022)
Figure 20. Global Felodipine Tablets Revenue Market Share by Application in 2021
Figure 21. Felodipine Tablets Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Felodipine Tablets Revenue Market Share by Company in 2021
Figure 23. Global Felodipine Tablets Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Felodipine Tablets Revenue Market Share by Geographic Region in 2021
Figure 25. Global Felodipine Tablets Sales Market Share by Region (2017-2022)
Figure 26. Global Felodipine Tablets Revenue Market Share by Country/Region in 2021
Figure 27. Americas Felodipine Tablets Sales 2017-2022 (K Units)
Figure 28. Americas Felodipine Tablets Revenue 2017-2022 ($ Millions)
Figure 29. APAC Felodipine Tablets Sales 2017-2022 (K Units)
Figure 30. APAC Felodipine Tablets Revenue 2017-2022 ($ Millions)
Figure 31. Europe Felodipine Tablets Sales 2017-2022 (K Units)
Figure 32. Europe Felodipine Tablets Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Felodipine Tablets Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Felodipine Tablets Revenue 2017-2022 ($ Millions)
Figure 35. Americas Felodipine Tablets Sales Market Share by Country in 2021
Figure 36. Americas Felodipine Tablets Revenue Market Share by Country in 2021
Figure 37. United States Felodipine Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Felodipine Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Felodipine Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Felodipine Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Felodipine Tablets Sales Market Share by Region in 2021
Figure 42. APAC Felodipine Tablets Revenue Market Share by Regions in 2021
Figure 43. China Felodipine Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Felodipine Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Felodipine Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Felodipine Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Felodipine Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Felodipine Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Felodipine Tablets Sales Market Share by Country in 2021
Figure 50. Europe Felodipine Tablets Revenue Market Share by Country in 2021
Figure 51. Germany Felodipine Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Felodipine Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Felodipine Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Felodipine Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Felodipine Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Felodipine Tablets Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Felodipine Tablets Revenue Market Share by Country in 2021
Figure 58. Egypt Felodipine Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Felodipine Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Felodipine Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Felodipine Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Felodipine Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Felodipine Tablets in 2021
Figure 64. Manufacturing Process Analysis of Felodipine Tablets
Figure 65. Industry Chain Structure of Felodipine Tablets
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles


Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets